Key result
This article reviews the most important risk factors for thrombosis and available therapeutic strategies for reducing vascular risk in polycythemia vera and essential thrombocythemia.
Why the study?
Thrombotic events are a dominant clinical feature of polycythemia vera and essential thrombocythemia, and estimating vascular risk and optimal antithrombotic strategy is crucial.
Answers are grounded in this paper and cite their sources.
This review summarizes the risk factors for thrombosis and available antithrombotic strategies in the management of polycythemia vera and essential thrombocythemia.
Thrombotic events are a dominant clinical feature of polycythemia vera and essential thrombocythemia. Estimating the vascular risk and choosing the best antithrombotic strategy are crucial issues in the management of these disorders. This article reviews the most important risk factors for thrombosis and focuses on the available therapeutic strategies for reducing the vascular risk. See related article on page 372.
No takes yet. Share an insight, caveat, or question.
Landolfi et al. (2008) conducted a review in Polycythemia vera and essential thrombocythemia. Therapeutic strategies for reducing vascular risk was evaluated. This article reviews the most important risk factors for thrombosis and available therapeutic strategies for reducing vascular risk in polycythemia vera and essential thrombocythemia.
Synapse has enriched 10 related papers. Consider them for comparative context: